Evercore Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $784K | Buy |
1,257
+3
| +0.2% | +$2.04K | 0.01% | 245 |
|
|
2026
Q1 | $969K | Buy |
1,254
+75
| +6% | +$57.4K | 0.02% | 220 |
|
|
2025
Q4 | $910K | Sell |
1,179
-12
| -1% | -$8.15K | 0.01% | 223 |
|
|
2025
Q3 | $670K | Sell |
1,191
-160
| -12% | -$90.5K | 0.01% | 257 |
|
|
2025
Q2 | $709K | Sell |
1,351
-22
| -2% | -$12.3K | 0.01% | 244 |
|
|
2025
Q1 | $871K | Buy |
1,373
+71
| +5% | +$48.8K | 0.01% | 230 |
|
|
2024
Q4 | $927K | Sell |
1,302
-3
| -0.2% | -$2.52K | 0.01% | 224 |
|
|
2024
Q3 | $1.37M | Hold |
1,305
| – | – | 0.02% | 194 |
|
|
2024
Q2 | $1.37M | Hold |
1,305
| – | – | 0.02% | 191 |
|
|
2024
Q1 | $1.26M | Sell |
1,305
-153
| -10% | -$145K | 0.02% | 199 |
|
|
2023
Q4 | $1.28M | Sell |
1,458
-1
| -0.1% | -$823 | 0.02% | 200 |
|
|
2023
Q3 | $1.2M | Sell |
1,459
-47
| -3% | -$36.9K | 0.02% | 198 |
|
|
2023
Q2 | $1.08M | Sell |
1,506
-106
| -7% | -$81.7K | 0.02% | 208 |
|
|
2023
Q1 | $1.32M | Sell |
1,612
-28
| -2% | -$21.1K | 0.03% | 186 |
|
|
2022
Q4 | $1.18M | Buy |
1,640
+173
| +12% | +$128K | 0.02% | 194 |
|
|
2022
Q3 | $1.01M | Buy |
1,467
+195
| +15% | +$123K | 0.02% | 201 |
|
|
2022
Q2 | $752K | Sell |
1,272
-6
| -0.5% | -$3.9K | 0.02% | 230 |
|
|
2022
Q1 | $893K | Sell |
1,278
-18
| -1% | -$11.4K | 0.02% | 237 |
|
|
2021
Q4 | $819K | Sell |
1,296
-45
| -3% | -$27.7K | 0.01% | 248 |
|
|
2021
Q3 | $812K | Sell |
1,341
-150
| -10% | -$93.1K | 0.01% | 237 |
|
|
2021
Q2 | $833K | Sell |
1,491
-3
| -0.2% | -$1.52K | 0.02% | 245 |
|
|
2021
Q1 | $707K | Buy |
1,494
+145
| +11% | +$70.6K | 0.01% | 254 |
|
|
2020
Q4 | $651K | Buy |
1,349
+63
| +5% | +$34K | 0.01% | 258 |
|
|
2020
Q3 | $719K | Sell |
1,286
-3
| -0.2% | -$1.82K | 0.02% | 227 |
|
|
2020
Q2 | $804K | Sell |
1,289
-9
| -0.7% | -$5.11K | 0.02% | 216 |
|
|
2020
Q1 | $634K | Buy |
1,298
+135
| +12% | +$55.7K | 0.02% | 216 |
|
|
2019
Q4 | $437K | Hold |
1,163
| – | – | 0.01% | 294 |
|
|
2019
Q3 | $322K | Sell |
1,163
-203
| -15% | -$60.1K | 0.01% | 326 |
|
|
2019
Q2 | $427K | Sell |
1,366
-188
| -12% | -$62.6K | 0.01% | 292 |
|
|
2019
Q1 | $638K | Buy |
1,554
+17
| +1% | +$7K | 0.02% | 244 |
|
|
2018
Q4 | $574K | Sell |
1,537
-7
| -0.5% | -$2.56K | 0.02% | 239 |
|
|
2018
Q3 | $624K | Sell |
1,544
-76
| -5% | -$28.9K | 0.02% | 253 |
|
|
2018
Q2 | $559K | Sell |
1,620
-20
| -1% | -$6.25K | 0.02% | 258 |
|
|
2018
Q1 | $565K | Sell |
1,640
-139
| -8% | -$48.3K | 0.02% | 232 |
|
|
2017
Q4 | $669K | Hold |
1,779
| – | – | 0.02% | 227 |
|
|
2017
Q3 | $795K | Buy |
1,779
+20
| +1% | +$9.52K | 0.03% | 198 |
|
|
2017
Q2 | $864K | Sell |
1,759
-109
| -6% | -$47.7K | 0.03% | 194 |
|
|
2017
Q1 | $724K | Sell |
1,868
-130
| -7% | -$48.2K | 0.03% | 217 |
|
|
2016
Q4 | $734K | Sell |
1,998
-319
| -14% | -$121K | 0.03% | 212 |
|
|
2016
Q3 | $932K | Sell |
2,317
-335
| -13% | -$134K | 0.04% | 183 |
|
|
2016
Q2 | $926K | Buy |
2,652
+152
| +6% | +$58.5K | 0.04% | 180 |
|
|
2016
Q1 | $901K | Buy |
2,500
+244
| +11% | +$101K | 0.04% | 181 |
|
|
2015
Q4 | $1.23M | Buy |
2,256
+345
| +18% | +$187K | 0.06% | 164 |
|
|
2015
Q3 | $892K | Sell |
1,911
-7
| -0.4% | -$3.76K | 0.04% | 190 |
|
|
2015
Q2 | $979K | Buy |
1,918
+533
| +38% | +$260K | 0.04% | 200 |
|
|
2015
Q1 | $625K | Buy |
1,385
+340
| +33% | +$144K | 0.03% | 245 |
|
|
2014
Q4 | $429K | Buy |
1,045
+92
| +10% | +$36.2K | 0.02% | 262 |
|
|
2014
Q3 | $345K | Buy |
953
+140
| +17% | +$46.9K | 0.02% | 316 |
|
|
2014
Q2 | $230K | Buy |
813
+60
| +8% | +$17.8K | 0.01% | 368 |
|
|
2014
Q1 | $226K | Buy |
753
+455
| +153% | +$140K | 0.01% | 353 |
|
|
2013
Q4 | $83K | Sell |
298
-11,260
| -97% | -$3.24M | ﹤0.01% | 482 |
|
|
2013
Q3 | $3.61M | Buy |
11,558
+98
| +0.9% | +$25.8K | 0.21% | 117 |
|
|
2013
Q2 | $2.58M | Buy |
+11,460
| New | +$2.67M | 0.15% | 141 |
|
Other funds holding REGN
Evercore Wealth Management's REGN Position: Q2 2026 in Review
Evercore Wealth Management increased its Regeneron Pharmaceuticals (REGN) stake by 0.24% in Q2 2026, buying an estimated $2.04K and bringing the position to 1,257 shares worth $784K. The position accounts for 0.01% of the portfolio, ranked #245.
Evercore Wealth Management first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.61M in Q3 2013. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Evercore Wealth Management held 1,257 shares of Regeneron Pharmaceuticals worth $784K as of Q2 2026.
- Evercore Wealth Management bought 3 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.04K.
- Regeneron Pharmaceuticals made up 0.01% of Evercore Wealth Management's portfolio in Q2 2026, its #245 holding.
- Evercore Wealth Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Evercore Wealth Management's Regeneron Pharmaceuticals position peaked at $3.61M in Q3 2013.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Evercore Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.